Access, knowledge and experience with fluorodeoxyglucose positron emission tomography/computed tomography in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists.
Abby P DouglasKarin A ThurskyLeon J WorthSimon J HarrisonRodney J HicksMonica A SlavinPublished in: Internal medicine journal (2020)
Access to FDG-PET/CT in Australia and New Zealand is modest and is limited by lack of reimbursement for infection indications. There is discrepancy between recognised ID indications for FDG-PET/CT and funded indications.